Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Colon Cancer treatment details. Chemotherapy. University of Pittsburgh School of Medicine, Pittsburgh, PA, United States

Survival: 10.1 months
Toxicity Grade: 4
Treatments: Chemotherapy
Country: United States
City/State/Province: Pittsburgh, PA
Hospital: University of Pittsburgh School of Medicine
Journal: Link
Date: 3/2006

Patients: This Phase II study involved 14 patients (11 men, 3 women, median age 70) with advanced colorectal cancer. All patients had received surgery or chemotherapy before the study.

Treatment: Treatment consisted of one chemotherapeutic agent: rubitecan.

Toxicity: Grade 3-4 toxicities included anemia, diarrhea and elevated bilirubin.

Results: The median overall survival was 10.1 months, and no objective responses were observed. The authors concluded, "Administration of rubitecan was well-tolerated, but this schedule does not appear to have clinical activity in patients with advanced previously treated colorectal cancer."

Correspondence: Ramesh K. Ramanathan

E-mail to a Friend Email Physician More Information